Pathology & Oncology Research

, Volume 14, Issue 3, pp 321–328 | Cite as

Alterations of the CD4+, CD8+ T Cell Subsets, Interleukins-1β, IL-10, IL-17, Tumor Necrosis Factor-α and Soluble Intercellular Adhesion Molecule-1 in Rheumatoid Arthritis and Osteoarthritis: Preliminary Observations

  • Mahmoud R. Hussein
  • Nehal A. Fathi
  • Azza M. Ezz. El-Din
  • Hewayda I. Hassan
  • Fatemah Abdullah
  • Eman AL-Hakeem
  • Eman Abo Backer
Original Paper


Rheumatoid arthritis is a multisystem disease with underlying immune mechanisms. Osteoarthritis is a debilitating, progressive disease of diarthrodial joints associated with the aging process. Although much is known about the pathogenesis of rheumatoid arthritis and osteoarthritis, our understanding of some immunologic changes remains incomplete. This study tries to examine the numeric changes in the T cell subsets and the alterations in the levels of some cytokines and adhesion molecules in these lesions. To accomplish this goal, peripheral blood and synovial fluid samples were obtained from 24 patients with rheumatoid arthritis, 15 patients with osteoarthritis and six healthy controls. The counts of CD4 + and CD8 + T lymphocytes were examined using flow cytometry. The levels of some cytokines (TNF-α, IL1-β, IL-10, and IL-17) and a soluble intercellular adhesion molecule-1 (sICAM-1) were measured in the sera and synovial fluids using enzyme linked immunosorbant assay. We found some variations in the counts of T cell subsets, the levels of cytokines and sICAM-1 adhesion molecule between the healthy controls and the patients with arthritis. High levels of IL-1β, IL-10, IL-17 and TNF-α (in the serum and synovial fluid) were observed in arthritis compared to the healthy controls. In rheumatoid arthritis, a high serum level of sICAM-1 was found compared to its level in the synovial fluid. A high CD4+/CD8+ T cell ratio was found in the blood of the patients with rheumatoid arthritis. In rheumatoid arthritis, the cytokine levels correlated positively with some clinicopathologic features. To conclude, the development of rheumatoid arthritis and osteoarthritis is associated with alteration of the levels of some cytokines. The assessment of these immunologic changes may have potential prognostic roles.


Rheumatoid arthritis Osteoarthritis T cells 


  1. 1.
    Maurer D, Felzmann T, Holter W, Petera P, Smolen J, Knapp W (1992) Evidence for the presence of activated CD4 T cells with naive phenotype in the peripheral blood of patients with rheumatoid arthritis. Clin Exp Immunol 87:429–434PubMedGoogle Scholar
  2. 2.
    Frye CA, Yocum DE, Tuan R, Suyana E, Seftor EA, Seftor RE, Khalkhali-Ellis Z, Moore TL, Hendrix MJ (1996) An in vitro model for studying mechanisms underlying synoviocyte-mediated cartilage invasion in rheumatoid arthritis. Pathol Oncol Res 2:157–166CrossRefPubMedGoogle Scholar
  3. 3.
    Khalkhali-Ellis Z, Bulla GA, Schlesinger LS, Kirschmann DA, Moore TL, Hendrix MJ (1999) C1q-containing immune complexes purified from sera of juvenile rheumatoid arthritis patients mediate IL-8 production by human synoviocytes: role of C1q receptors. J Immunol 163:4612–4620PubMedGoogle Scholar
  4. 4.
    Choy EH, Connolly DJ, Rapson N, Jeal S, Brown JC, Kingsley GH, Panayi GS, Johnston JM (2000) Pharmacokinetic, pharmacodynamic and clinical effects of a humanized IgG1 anti-CD4 monoclonal antibody in the peripheral blood and synovial fluid of rheumatoid arthritis patients. Rheumatology (Oxford) 39:1139–1146CrossRefGoogle Scholar
  5. 5.
    Khalkhali-Ellis Z, Roodman ST, Knutsen AP, Mueller KR, Chauhan B, Moore TL, Hendrix MJ (1998) Expression of macrophage markers by a population of T cells obtained from synovial fluid of a subgroup of patients with juvenile rheumatoid arthritis. J Rheumatol 25:352–360PubMedGoogle Scholar
  6. 6.
    Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, Saito S, Inoue K, Kamatani N, Gillespie MT, Martin TJ, Suda T (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103:1345–1352CrossRefPubMedGoogle Scholar
  7. 7.
    Zwerina J, Redlich K, Schett G, Smolen JS (2005) Pathogenesis of rheumatoid arthritis: targeting cytokines. Ann N Y Acad Sci 1051:716–729CrossRefPubMedGoogle Scholar
  8. 8.
    Malemud CJ (2004) Cytokines as therapeutic targets for osteoarthritis. BioDrugs 18:23–35CrossRefPubMedGoogle Scholar
  9. 9.
    Aigner T, Sachse A, Gebhard PM, Roach HI (2006) Osteoarthritis: pathobiology-targets and ways for therapeutic intervention. Adv Drug Deliv Rev 58:128–149CrossRefPubMedGoogle Scholar
  10. 10.
    Zangerle PF, De Groote D, Lopez M, Meuleman RJ, Vrindts Y, Fauchet F, Dehart I, Jadoul M, Radoux D, Franchimont P (1992) Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis. Cytokine 4:568–575CrossRefPubMedGoogle Scholar
  11. 11.
    Ezawa K, Yamamura M, Matsui H, Ota Z, Makino H (1997) Comparative analysis of CD45RA- and CD45RO-positive CD4 + T cells in peripheral blood, synovial fluid, and synovial tissue in patients with rheumatoid arthritis and osteoarthritis. Acta Med Okayama 51:25–31PubMedGoogle Scholar
  12. 12.
    Petrovic-Rackov L, Pejnovic N (2005) Clinical significance of IL-18, IL-15, IL-12 and TNF-alpha measurement in rheumatoid arthritis. Clin Rheumatol 25:448–452CrossRefPubMedGoogle Scholar
  13. 13.
    Firestein GS (2005) Immunologic mechanisms in the pathogenesis of rheumatoid arthritis. J Clin Rheumatol 11(3 Suppl):S39–44CrossRefPubMedGoogle Scholar
  14. 14.
    Abramson SB, Amin A (2002) Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage. Rheumatology (Oxford) 41:972–980CrossRefGoogle Scholar
  15. 15.
    Attur MG, Patel IR, Patel RN, Abramson SB, Amin AR (1998) Autocrine production of IL-1 beta by human osteoarthritis-affected cartilage and differential regulation of endogenous nitric oxide, IL-6, prostaglandin E2, and IL-8. Proc Assoc Am Physicians 110:65–72PubMedGoogle Scholar
  16. 16.
    Appel H, Neure L, Kuhne M, Braun J, Rudwaleit M, Sieper J (2004) An elevated level of IL-10- and TGFbeta-secreting T cells, B cells and macrophages in the synovial membrane of patients with reactive arthritis compared to rheumatoid arthritis. Clin Rheumatol 23:435–440CrossRefPubMedGoogle Scholar
  17. 17.
    Verhoef CM, van Roon JA, Vianen ME, Bijlsma JW, Lafeber FP (2001) Interleukin 10 (IL-10), not IL-4 or interferon-gamma production, correlates with progression of joint destruction in rheumatoid arthritis. J Rheumatol 28:1960–1966PubMedGoogle Scholar
  18. 18.
    Miossec P (2004) IL-17 in rheumatoid arthritis: a new target for treatment or just another cytokine? Joint Bone Spine 71:87–90CrossRefPubMedGoogle Scholar
  19. 19.
    Ryu S, Lee JH, Kim SI (2006) IL-17 increased the production of vascular endothelial growth factor in rheumatoid arthritis synoviocytes. Clin Rheumatol 25:16–20CrossRefPubMedGoogle Scholar
  20. 20.
    Lindsley HB, Smith DD, Davis LS, Koch AE, Lipsky PE (1992) Regulation of the expression of adhesion molecules by human synoviocytes. Semin Arthritis Rheum 21:330–334CrossRefPubMedGoogle Scholar
  21. 21.
    Cush JJ, Rothlein R, Lindsley HB, Mainolfi EA, Lipsky PE (1993) Increased levels of circulating intercellular adhesion molecule 1 in the sera of patients with rheumatoid arthritis. Arthritis Rheum 36:1098–1102CrossRefPubMedGoogle Scholar
  22. 22.
    Gonzalez-Gay MA, Garcia-Unzueta MT, De Matias JM, Gonzalez-Juanatey C, Garcia-Porrua C, Sanchez-Andrade A, Martin J, Llorca J (2006) Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis. Clin Exp Rheumatol 24:373–379PubMedGoogle Scholar
  23. 23.
    Albert DA, Huang G, Dubrow G, Brensinger CM, Berlin JA, Williams HJ (2004) Criteria for improvement in rheumatoid arthritis: alternatives to the American College of Rheumatology 20. J Rheumatol 31(5):856–866PubMedGoogle Scholar
  24. 24.
    Hussein MR, Hassan HI, Hofny ER, Elkholy M, Fatehy NA, Abd Elmoniem AE, Ezz El-Din AM, Afifi OA, Rashed HG (2005) Alterations of mononuclear inflammatory cells, CD4/CD8 + T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis. J Clin Pathol 58:178–184CrossRefPubMedGoogle Scholar
  25. 25.
    Barrera P, Faure S, Prud’homme JF, Balsa A, Migliorini P, Chimenti D, Radstake TR, van de Putte LB, Pascual-Salcedo D, Westhovens R, Maenaut K, Alves H, Lopes-Vaz A, Stravopoulos C, Spyropoulou M, Fritz P, Bardin T, Charron D, Lepage V, Alibert, Martinez M, Cornelis F (2001) European genetic study on rheumatoid arthritis: is there a linkage of the interleukin-1 (IL-1), IL-10 or IL-4 genes to RA? Clin Exp Rheumatol 19:709–714PubMedGoogle Scholar
  26. 26.
    Chabaud M, Page G, Miossec P (2001) Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines. J Immunol 167:6015–6020PubMedGoogle Scholar
  27. 27.
    Petrovic-Rackov L (2006) Evaluation of the degree of clinical rheumatoid arthritis activity based on the concentrations of cytokines TNF-alpha, IL-12, IL-15, and IL-18 in serum and synovial fluid]. Vojnosanit Pregl 63:21–26PubMedGoogle Scholar
  28. 28.
    Brennan FM, Hayes AL, Ciesielski CJ, Green P, Foxwell BM, Feldmann M (2002) Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis. Arthritis Rheum 46:31–41CrossRefPubMedGoogle Scholar
  29. 29.
    Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, Pin JJ, Garrone P, Garcia E, Saeland S, Blanchard D, Gaillard C, Das Mahapatra B, Rouvier E, Golstein P, Banchereau J, Lebecque S (1998) T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183:2593–2603CrossRefGoogle Scholar
  30. 30.
    Chabaud M, Fossiez F, Taupin JL, Miossec P (1998) Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol 161:409–414PubMedGoogle Scholar
  31. 31.
    Khalkhali-Ellis Z, Seftor EA, Nieva DR, Seftor RE, Samaha HA, Bultman L, De Larco JE, Ince A, Moore TL, Hendrix MJ (1997) Induction of invasive and degradative phenotype in normal synovial fibroblasts exposed to synovial fluid from patients with juvenile rheumatoid arthritis: role of mononuclear cell population. J Rheumatol 24:2451–2460PubMedGoogle Scholar
  32. 32.
    Cush JJ, Splawski JB, Thomas R, McFarlin JE, Schulze-Koops H, Davis LS, Fujita K, Lipsky PE (1995) Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum 38:96–104CrossRefPubMedGoogle Scholar
  33. 33.
    Macchioni P, Boiardi L, Casali B, Nicoli D, Farnetti E, Salvarani C (2000) Intercellular adhesion molecule 1 (ICAM-1) gene polymorphisms in Italian patients with rheumatoid arthritis. Clin Exp Rheumatol 18:553–558PubMedGoogle Scholar
  34. 34.
    Blann AD, Herrick A, Jayson MI (1995) Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis. Br J Rheumatol 34:814–819CrossRefPubMedGoogle Scholar
  35. 35.
    Dolezalova P, Telekesova P, Nemcova D, Hoza J (2002) Soluble adhesion molecules ICAM-1 and E-selectin in juvenile arthritis: clinical and laboratory correlations. Clin Exp Rheumatol 20:249–254PubMedGoogle Scholar
  36. 36.
    Hanyuda M, Kasama T, Isozaki T, Matsunawa MM, Yajima N, Miyaoka H, Uchida H, Kameoka Y, Ide H, Adachi M (2003) Activated leucocytes express and secrete macrophage inflammatory protein-1alpha upon interaction with synovial fibroblasts of rheumatoid arthritis via a beta2-integrin/ICAM-1 mechanism. Rheumatology (Oxford) 42:1390–1397CrossRefGoogle Scholar
  37. 37.
    Pigott R, Dillon LP, Hemingway IH, Gearing AJ (1992) Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 187:584–589CrossRefPubMedGoogle Scholar
  38. 38.
    Lindsley HB, Smith DD, Cohick CB, Koch AE, Davis LS (1993) Proinflammatory cytokines enhance human synoviocyte expression of functional intercellular adhesion molecule-1 (ICAM-1). Clin Immunol Immunopathol 68:311–320CrossRefPubMedGoogle Scholar
  39. 39.
    Fitzgerald JE, Ricalton NS, Meyer AC, West SG, Kaplan H, Behrendt C, Kotzin BL (1995) Analysis of clonal CD8 + T cell expansions in normal individuals and patients with rheumatoid arthritis. J Immunol 154:3538–3547PubMedGoogle Scholar
  40. 40.
    Burmester GR, Stuhlmuller B, Keyszer G, Kinne RW (1997) Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis? Arthritis Rheum 40:5–18CrossRefPubMedGoogle Scholar
  41. 41.
    Benito MJ, Veale DJ, FitzGerald O, van den Berg WB, Bresnihan B (2005) Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis 64:1263–1267CrossRefPubMedGoogle Scholar
  42. 42.
    Miltenburg AM, van Laar JM, de Kuiper R, Daha MR, Breedveld FC (1992) T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand J Immunol 35:603–610CrossRefPubMedGoogle Scholar
  43. 43.
    Rittner HL, Zettl A, Jendro MC, Bartz-Bazzanella P, Goronzy JJ, Weyand CM (1997) Multiple mechanisms support oligoclonal T cell expansion in rheumatoid synovitis. Mol Med 3:452–465PubMedGoogle Scholar
  44. 44.
    Steiner G, Tohidast-Akrad M, Witzmann G, Vesely M, Studnicka-Benke A, Gal A, Kunaver M, Zenz P, Smolen JS (1999) Cytokine production by synovial T cells in rheumatoid arthritis. Rheumatology (Oxford) 38:202–213CrossRefGoogle Scholar
  45. 45.
    Franz JK, Kolb SA, Hummel KM, Lahrtz F, Neidhart M, Aicher WK, Pap T, Gay RE, Fontana A, Gay S (1998) Interleukin-16, produced by synovial fibroblasts, mediates chemoattraction for CD4 + T lymphocytes in rheumatoid arthritis. Eur J Immunol 28:2661–2671CrossRefPubMedGoogle Scholar
  46. 46.
    Mamoune A, Durand V, Le Goff P, Pennec YL, Youinou P, Le Corre R (2000) Abnormal distribution of CD45 isoforms expressed by CD4 + and CD8 + T cells in rheumatoid arthritis. Histol Histopathol 15:587–591PubMedGoogle Scholar
  47. 47.
    Hatachi S, Iwai Y, Kawano S, Morinobu S, Kobayashi M, Koshiba M, Saura R, Kurosaka M, Honjo T, Kumagai S (2003) CD4 + PD-1 + T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid. J Rheumatol 30:1410–1419PubMedGoogle Scholar
  48. 48.
    van Amelsfort JM, Jacobs KM, Bijlsma JW, Lafeber FP, Taams LS (2004) CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 50:2775–2785CrossRefPubMedGoogle Scholar
  49. 49.
    Mottonen M, Heikkinen J, Mustonen L, Isomaki P, Luukkainen R, Lassila O (2005) CD4 + CD25 + T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 140:360–367CrossRefPubMedGoogle Scholar
  50. 50.
    Mallya RK, Mace BE (1981) The assessment of disease activity in rheumatoid arthritis using a multivariate analysis. Rheumatol Rehabil 20:14–17CrossRefPubMedGoogle Scholar

Copyright information

© Arányi Lajos Foundation 2008

Authors and Affiliations

  • Mahmoud R. Hussein
    • 4
  • Nehal A. Fathi
    • 1
  • Azza M. Ezz. El-Din
    • 2
  • Hewayda I. Hassan
    • 3
  • Fatemah Abdullah
    • 1
  • Eman AL-Hakeem
    • 1
  • Eman Abo Backer
    • 1
  1. 1.Departments of Rheumatology and Rehabilitation, Faculty of Medicine, Assuit University HospitalsAssuit and Ein Shams UniversitiesAssuitEgypt
  2. 2.Clinical Pathology, Faculty of MedicineAssuit University HospitalsAssuitEgypt
  3. 3.Pathology Department, Faculty of MedicineAssuit University HospitalsAssuitEgypt
  4. 4.Pathology Departments, Faculty of MedicineAssuit University and Assir Central HospitalsAssuitEgypt

Personalised recommendations